Harleen K Sahni, MD
Infectious Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
22 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sahni’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102121 · Current
Licensed to practise in California · since 2007 · expires 2027-04-30 · University of Calcutta Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$5,062
Medicare paid this office $5,062 for 85 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,752 | $117 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $795 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $778 | $71 |
| X-ray of chest, 1 view | 49 | $764 | $14 |
Who their Medicare patients are
85 Original Medicare patients in 2024. Average age 73 · Women 46% · Health risk score 2.19. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 42% · Chronic kidney disease 33% · Coronary heart disease 29% · Heart failure 25% · Atrial fibrillation 21% · COPD 18% · Depression 18% · Stroke 14%.
The office billed $70,195, Medicare allowed $6,668 and paid $5,062; for 116 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 85 | 116 | 73 | 2.19 | $70,195 | $5,062 |
| 2023 | 113 | 177 | 73 | 2.75 | $112,510 | $9,463 |
| 2022 | 68 | 117 | 72 | 2.50 | $77,392 | $7,697 |
| 2021 | 61 | 99 | 72 | 2.85 | $60,711 | $5,987 |
| 2020 | 50 | 131 | 68 | 3.81 | $95,465 | $11,610 |
| 2019 | 48 | 119 | 69 | 3.36 | $65,690 | $7,740 |
| 2018 | 60 | 164 | 69 | 3.09 | $65,439 | $9,451 |
| 2017 | 50 | 119 | 69 | 3.33 | $50,953 | $7,740 |
| 2016 | 50 | 162 | 68 | 3.15 | $62,988 | $10,532 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,258 | $121 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $2,405 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,240 | $78 |
| X-ray of chest, 1 view | 63 | $791 | $11 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $3,022 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,357 | $147 |
| X-ray of chest, 1 view | 34 | $542 | $14 |
2021: 3 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,411 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,008 | $77 |
| X-ray of chest, 1 view | 34 | $528 | $14 |
2020: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,881 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,600 | $153 |
2019: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $3,579 | $66 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,566 | $63 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $1,830 | $87 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $746 | $34 |
| X-ray of chest, 1 view | 14 | $147 | $10 |
2017: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $3,563 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,077 | $90 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $4,180 | $64 |
| Return visit (30+ min) | 12 | $2,207 | $69 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $593 | $35 |
Medicaid work
$939,397 in 2024
Medicaid paid $939,397 for 24,832 billed services this clinician did in 2024, up to 263 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,627 | $841,101 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 46 | $20,528 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 343 | $19,118 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 147 | $5,826 |
| Short return visit | 2,480 | $5,777 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 147 | $5,653 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 346 | $5,627 |
| Short return visit (20+ min) | 1,469 | $5,162 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 348 | $4,066 |
| HEPATITIS C ANTIBODY | 202 | $3,260 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 282 | $3,114 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 333 | $2,938 |
| 2024 | 24,832 | 42 | 263 | $939,397 |
| 2023 | 14,108 | 36 | 197 | $1,190,896 |
| 2022 | 9,307 | 39 | 208 | $758,836 |
| 2021 | 5,292 | 36 | 120 | $519,247 |
| 2020 | 961 | 6 | 81 | $184,061 |
| 2019 | 550 | 4 | 32 | $113,190 |
| 2018 | 765 | 7 | 38 | $153,959 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,252 | $1,123,168 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 286 | $15,839 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 283 | $5,513 |
| Short return visit | 2,819 | $5,283 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 124 | $4,902 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 124 | $4,756 |
| Short return visit (20+ min) | 1,449 | $4,291 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 286 | $3,320 |
| Return visit (30+ min) | 649 | $3,107 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 286 | $2,503 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 350 | $2,327 |
| HEPATITIS C ANTIBODY | 125 | $2,010 |
2022
| Clinic visit/encounter, all-inclusive | 1,467 | $706,457 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 222 | $12,294 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 119 | $4,733 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 119 | $4,592 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 249 | $4,288 |
| Short return visit | 1,176 | $3,613 |
| Short return visit (20+ min) | 995 | $2,924 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 223 | $2,589 |
| HEPATITIS C ANTIBODY | 135 | $2,180 |
| Return visit (30+ min) | 405 | $1,543 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 163 | $1,424 |
| Antibody; varicella-zoster | 94 | $1,332 |
2021
| Clinic visit/encounter, all-inclusive | 1,052 | $493,297 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 108 | $6,029 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 189 | $2,984 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 49 | $1,949 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 48 | $1,852 |
| Short return visit | 543 | $1,702 |
| Short return visit (20+ min) | 775 | $1,482 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 111 | $1,299 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 75 | $1,081 |
| HEPATITIS C ANTIBODY | 52 | $841 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 84 | $743 |
| MYCOBACTERIA CULTURE | 53 | $691 |
2020
| Clinic visit/encounter, all-inclusive | 390 | $181,047 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 145 | $2,023 |
| Short return visit (20+ min) | 317 | $453 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $269 |
| Short return visit | 76 | $165 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 13 | $102 |
2019
| Clinic visit/encounter, all-inclusive | 246 | $111,689 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 104 | $996 |
| Short return visit (20+ min) | 179 | $415 |
| Return visit (30+ min) | 21 | $90 |
2018
| Clinic visit/encounter, all-inclusive | 335 | $149,967 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 169 | $2,387 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 46 | $812 |
| Short return visit (20+ min) | 165 | $657 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 21 | $101 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 15 | $35 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
Drugs they prescribed that Part D paid
$59,338
Pharmacies billed $59,338 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 330) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
290 generic and 40 brand-name prescriptions · $59,338 in drug cost · 62 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Posaconazole | 11 | $10,865 | $988 |
| Rifabutin | 19 | $10,284 | $541 |
| Pyrazinamide | 15 | $3,800 | $253 |
| Rifampin | 81 | $3,308 | $41 |
| Ethambutol | 24 | $1,230 | $51 |
See all 9 drugs
| Posaconazole | 11 | $10,865 | $988 |
| Rifabutin | 19 | $10,284 | $541 |
| Pyrazinamide | 15 | $3,800 | $253 |
| Rifampin | 81 | $3,308 | $41 |
| Ethambutol | 24 | $1,230 | $51 |
| Azithromycin | 27 | $904 | $33 |
| Amikacin Sulfate | 12 | $630 | $53 |
| Linezolid | 14 | $441 | $31 |
| Isoniazid | 63 | $359 | $6 |
Year by year
| 2024 | 330 | 41 | 0% (0) | 12% | $59,338 |
| 2023 | 368 | 53 | 0% (0) | 12% | $106,646 |
| 2022 | 268 | 39 | 0% (0) | 5% | $41,159 |
| 2021 | 223 | 34 | 0% (0) | 17% | $57,261 |
| 2020 | 150 | 36 | 0% (0) | 11% | $28,214 |
| 2019 | 74 | 20 | 0% (0) | None | $17,190 |
| 2018 | 102 | 29 | 0% (0) | None | $10,356 |
| 2017 | 93 | 27 | 0% (0) | 15% | $8,480 |
| 2016 | 165 | 31 | None | 26% | $60,354 |
| 2015 | 125 | 28 | 0% (0) | 9% | $11,060 |
| 2014 | 139 | 20 | None | 25% | $20,415 |
| 2013 | 23 | None | 0% (0) | None | $944 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Posaconazole | 13 | $17,780 | $1,368 |
| Rifabutin | 26 | $16,090 | $619 |
| Pyrazinamide | 29 | $8,241 | $284 |
| Rifampin | 81 | $4,651 | $57 |
| Ethambutol | 49 | $2,918 | $60 |
| Azithromycin | 30 | $737 | $25 |
| Isoniazid | 68 | $464 | $7 |
| Levofloxacin | 15 | $202 | $13 |
2022: 6 drugs
| Posaconazole | 11 | $23,906 | $2,173 |
| Rifampin | 87 | $6,340 | $73 |
| Pyrazinamide | 14 | $3,962 | $283 |
| Ethambutol | 31 | $1,659 | $54 |
| Azithromycin | 29 | $879 | $30 |
| Isoniazid | 54 | $388 | $7 |
2021: 6 drugs
| Posaconazole | 13 | $34,128 | $2,625 |
| Rifabutin | 13 | $11,043 | $849 |
| Rifampin | 61 | $3,872 | $63 |
| Ethambutol | 35 | $2,238 | $64 |
| Azithromycin | 15 | $829 | $55 |
| Isoniazid | 45 | $331 | $7 |
2020: 4 drugs
| Pyrazinamide | 11 | $3,488 | $317 |
| Rifampin | 43 | $2,104 | $49 |
| Ethambutol | 11 | $866 | $79 |
| Isoniazid | 37 | $244 | $7 |
2019: 1 drug
| Isoniazid | 19 | $130 | $7 |
2018: 3 drugs
| Pyrazinamide | 14 | $4,459 | $319 |
| Rifampin | 23 | $1,587 | $69 |
| Isoniazid | 11 | $75 | $7 |
2017: 2 drugs
| Rifampin | 19 | $1,287 | $68 |
| Isoniazid | 21 | $132 | $6 |
2016: 4 drugs
| Invanz | 14 | $9,477 | $677 |
| Rifampin | 36 | $1,882 | $52 |
| Ethambutol | 15 | $1,150 | $77 |
| Isoniazid | 24 | $140 | $6 |
2015: 3 drugs
| Rifampin | 24 | $1,557 | $65 |
| Ethambutol | 11 | $901 | $82 |
| Isoniazid | 30 | $184 | $6 |
2014: 4 drugs
| Pyrazinamide | 14 | $2,403 | $172 |
| Ethambutol | 22 | $1,913 | $87 |
| Rifampin | 18 | $1,546 | $86 |
| Isoniazid | 21 | $150 | $7 |
Money from drug and device companies
$60 in 2025
A payment is not proof that care is biased.
| Insmed | Arikayce | $60 | 1 payment
|
See the published payment
| Insmed | Education · 2025-01-17 | Arikayce | $60 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1801071303
- Licence
- CA A102121California A102121: Current · expires 2027-04-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Internal Medicine, San Jose, CA, 95128
- NPI first listed
- 2008-01-02
- NPI last updated
- 2014-12-03
This is when the NPI record was last certified, not a medical board exam.